Northpointe Capital’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
RIM
FLAM
EA
EMFAT
BFA
Northpointe Capital's ATRC Position: Q1 2016 in Review
Northpointe Capital sold out of AtriCure (ATRC) in Q1 2016, closing a stake of 507,795 shares — an estimated $11.1M sold.
Northpointe Capital first reported a position in ATRC in Q2 2013 and held it in 11 quarters. The position peaked at $19.7M in Q1 2015. 113 funds tracked by Wall St. Rank hold ATRC as of Q1 2016.
- Northpointe Capital reported no remaining AtriCure position as of Q1 2016 after selling out during the quarter.
- Northpointe Capital sold 507,795 AtriCure shares in Q1 2016, an estimated $11.1M.
- Northpointe Capital first reported a position in AtriCure in Q2 2013 and held it in 11 quarters.
- Northpointe Capital's AtriCure position peaked at $19.7M in Q1 2015.
- 113 funds tracked by Wall St. Rank held AtriCure as of Q1 2016.
Based on Northpointe Capital's 13F filing for Q1 2016, filed 28 Apr 2016.